According to this latest study, the 2021 growth of Non-Invasive Liquid Biopsy will have significant change from previous year. By the most conservative estimates of global Non-Invasive Liquid Biopsy market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Non-Invasive Liquid Biopsy market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Invasive Liquid Biopsy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Stool Test
Urine Test
Saliva Test
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospital
Laboratory
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bio-Techne
Endress+Hauser
Exact Sciences Corporation
Lonza Group AG
MDxHealth
Merck KGaA
MutantDx
Norgen Biotek Corp
Nucleix
Oasis Diagnostics Corporation
OraSure Technologies
PerkinElmer
Predicine
Qiagen
Thermo Fisher Scientific
Zymo Research Corporation